We have advised a fast growing Ducth biotech company in a complex patent and know-how license deal, with regard to proprietary monoclonal antibodies, with one of the largest international pharmaceutical companies worldwide (2014). We have assisted our client in preparing the deal terms, inter alia with the selection and presentation of information, provided an opinion on the validity of patents of third parties and negotiated the contract.
